arrow
D

Domenico Tamburrino

vita-salute san raffaele university
H指数:32
被引数:2,628

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EUS-guided drainage of Post-Surgical versus Post-Pancreatitis collections (the RESPELL study): A prospective comparison of clinical presentations and therapeutic outcomes
2026-01-220
OAAI
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial

术前mFOLFIRINOX与PAXG对比治疗I~III期可切除及临界可切除胰腺导管腺癌(PACT-21 CASSANDRA):一项随机、开放标签、2×2析因设计III期试验的首个随机化分析结果

2025-11-200
PRE
Results of a randomized phase III trial of pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III pancreatic ductal adenocarcinoma

一项关于术前化疗联合mFOLFIRINOX或PAXG方案治疗I-III期胰腺导管腺癌的随机III期试验结果

2025-10-310
PRE
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness

解剖学可切除与生物学临界可切除胰腺癌定义:超越解剖标准和生物学侵袭性的边界界定

2025-05-201
OA
Diagnostic delay at diagnosis and time-to-treatment influence overall survival of pancreatic cancer patients

诊断延迟和从诊断到治疗的时间影响胰腺癌患者的总生存期

2025-04-020
PRE
Surgery for chronic pancreatitis across Europe (ESCOPA): prospective multicentre study
2025-01-010
OAAI
The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine Tumors
2024-03-220
PRE
The Value of Textbook Outcome in Benchmarking Pancreatoduodenectomy for Nonfunctioning Pancreatic Neuroendocrine Tumors

教科书结果对无功能胰腺神经内分泌肿瘤胰十二指肠切除术的基准价值

2024-03-104
PRE
REDISCOVER International Guidelines on the Perioperative Care of Surgical Patients With Borderline-resectable and Locally Advanced Pancreatic Cancer
2024-02-2611
OAAI